MaxCyte Balance Sheet
NASDAQ: MXCTHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
MaxCyte financial position
At the end of fiscal 2025, MaxCyte reported total assets of $202.5 million, down 15.4% from a year earlier against total liabilities of $31.0 million. Shareholders' equity stood at $171.5 million, or 84.7% of assets. The company held $20.1 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 8.30, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
MaxCyte balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 20.07M | 27.88M | 46.51M | 11.06M | 47.78M | 18.76M | 15.21M |
| Short-Term Investments | 82.98M | 126.60M | 121.78M | 216.28M | 207.26M | 16.01M | — |
| Receivables | 3.50M | 4.68M | 5.78M | 11.18M | 6.88M | 5.17M | — |
| Inventory | 7.55M | 8.91M | 12.23M | 8.58M | 5.20M | 4.32M | — |
| Total Current Assets | 118.37M | 171.68M | 190.19M | 252.27M | 270.43M | 45.25M | — |
| Property, Plant & Equipment | 17.53M | 19.71M | 23.51M | 23.73M | 7.68M | 4.55M | — |
| Intangible Assets | 650.00K | — | — | — | — | — | — |
| Long-Term Investments | 52.57M | 35.78M | 42.94M | — | — | — | — |
| Total Assets | 202.51M | 239.47M | 268.27M | 286.65M | 284.12M | 51.78M | — |
| Accounts Payable | 1.40M | 1.36M | 743.00K | 292.00K | 1.82M | 890.20K | — |
| Total Current Liabilities | 14.27M | 15.78M | 17.86M | 15.43M | 15.62M | 11.61M | — |
| Long-Term Debt | — | — | — | — | — | 4.92M | — |
| Total Liabilities | 31.02M | 33.22M | 36.11M | 32.69M | 21.22M | 18.55M | — |
| Shareholders' Equity | 171.49M | 206.25M | 232.17M | 253.97M | 262.90M | 33.23M | 13.60M |
| Retained Earnings | -261.48M | -216.85M | -175.80M | -137.88M | -114.30M | -95.22M | — |
| Total Debt | — | — | — | — | — | 4.92M | — |
| Net Cash (Debt) | 103.04M | 154.48M | 168.29M | 227.34M | 255.04M | 29.85M | 15.21M |
| Shares Outstanding | 106.79M | 105.71M | 103.96M | 102.40M | 101.20M | 77.38M | — |
This table shows 7 annual periods of MaxCyte's balance sheet, from FY 2025 back to FY 2019, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow MXCT's reporting calendar. What is a balance sheet?